We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$39.1B
AUM Growth
-$26.3M
Cap. Flow
+$1.59B
Cap. Flow %
4.07%
Top 10 Hldgs %
39.91%
Holding
738
New
84
Increased
295
Reduced
215
Closed
110

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$499M
2
SNPS icon
Synopsys
SNPS
+$411M
3
MSFT icon
Microsoft
MSFT
+$380M
4
NFLX icon
Netflix
NFLX
+$354M
5
CI icon
Cigna
CI
+$177M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$546M
2
WFC icon
Wells Fargo
WFC
+$453M
3
PR
Permian Resources
PR
+$229M
4
ELV icon
Elevance Health
ELV
+$195M
5
NVDA icon
NVIDIA
NVDA
+$97.3M

Sector Composition

Rank Sector Weight
1 Technology 31.72%
2 Healthcare 23.65%
3 Communication Services 11.87%
4 Financials 10.29%
5 Consumer Discretionary 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPS icon
76
United Parcel Service
UPS
$97.6B
$45.4M 0.12%
461,048
+33,665
+8% +$3.61M
BTI icon
77
British American Tobacco
BTI
$132B
$44.8M 0.11%
766,683
-755,049
-50% -$44.7M
ALL icon
78
Allstate
ALL
$66.9B
$43.8M 0.11%
211,404
+124,602
+144% +$25.5M
CX icon
79
Cemex
CX
$17.4B
$43.7M 0.11%
3,819,356
+763,225
+25% +$9.1M
NUE icon
80
Nucor
NUE
$56.4B
$43.6M 0.11%
257,987
+14,050
+6% +$2.45M
STLA icon
81
Stellantis
STLA
$16.5B
$43.2M 0.11%
6,187,512
+1,483,027
+32% +$12.4M
YPF icon
82
YPF
YPF
$20.2B
$42.8M 0.11%
926,178
-219,700
-19% -$8.31M
REGN icon
83
Regeneron Pharmaceuticals
REGN
$68.8B
$42.8M 0.11%
55,353
-1,351
-2% -$1.03M
COF icon
84
Capital One
COF
$124B
$42.2M 0.11%
231,068
+14,664
+7% +$3.07M
NVS icon
85
Novartis
NVS
$295B
$42.1M 0.11%
275,637
-23,538
-8% -$3.61M
VALE icon
86
Vale
VALE
$62.9B
$41.9M 0.11%
2,632,354
+2,315,054
+730% +$36.1M
FCX icon
87
Freeport-McMoran
FCX
$90B
$41.2M 0.11%
701,125
-253,400
-27% -$15.3M
CTVA icon
88
Corteva
CTVA
$59.7B
$40.1M 0.1%
479,331
-30,900
-6% -$2.33M
ITRI icon
89
Itron
ITRI
$3.73B
$40.1M 0.1%
447,140
+226,019
+102% +$21.7M
SLF icon
90
Sun Life Financial
SLF
$45.6B
$39.8M 0.1%
637,630
+108,109
+20% +$6.91M
ROP icon
91
Roper Technologies
ROP
$36.3B
$39.6M 0.1%
+111,931
New +$41.3M
CTSH icon
92
Cognizant
CTSH
$21.5B
$39M 0.1%
635,403
+111,161
+21% +$7.95M
CLH icon
93
Clean Harbors
CLH
$16.1B
$38.9M 0.1%
135,593
+26,772
+25% +$7.31M
PSMT icon
94
Pricesmart
PSMT
$5.75B
$38.8M 0.1%
257,970
-35,218
-12% -$5.14M
PYPL icon
95
PayPal
PYPL
$49.5B
$38.3M 0.1%
847,259
+238,541
+39% +$11.5M
BF.B icon
96
Brown-Forman Class B
BF.B
$12B
$38.1M 0.1%
1,439,650
+99,919
+7% +$2.68M
OTEX icon
97
Open Text
OTEX
$5.43B
$37.8M 0.1%
1,700,642
+291,392
+21% +$7.57M
CRUS icon
98
Cirrus Logic
CRUS
$6.74B
$36.5M 0.09%
252,333
+19,271
+8% +$2.59M
BCPC
99
Balchem Corp
BCPC
$5.23B
$36.1M 0.09%
212,718
+2,874
+1% +$488K
NWE icon
100
NorthWestern Energy
NWE
$4.48B
$36M 0.09%
546,033
+62,742
+13% +$4.25M

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2026 Portfolio in Review

As of Q1 2026, Grantham, Mayo, Van Otterloo & Co (GMO) held 738 positions worth $39.1B, down 0.07% from $39.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) deployed $1.59B of net new capital in Q1 2026, opening 84 new positions and adding to 295 existing holdings. Its largest new stake was Synopsys: 910,133 shares worth $361M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Lam Research, an estimated $546M trimmed.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2026 buy was Synopsys: 910,133 shares worth $361M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Mastercard in Q1 2026, an estimated $499M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2026 reduction was Lam Research, cutting an estimated $546M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Comerica in Q1 2026, selling an estimated $36.8M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 40% of its $39.1B portfolio in Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 84 new positions and closed 110 in Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 0.07% quarter-over-quarter to $39.1B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.